Summary
Avodart (Dutasteride) is a drug similar to Propecia / Finasteride, in that it blocks the enzyme that converts Testosterone to DHT. Unlike Finasteride, Avodart blocks both of the enzymes that create DHT instead of just one, so it may be a more potent treatment for hair loss. It is also, as far as we have been able to ascertain, the nearest new drug to FDA approval for hair loss.
Specifics
Treatment Type:
Dual 5-alpha Reductase Inhibitor
Testing Progress:
Approved for Benign Prostatic Hyperplasia (BPH)
Phase III trials for hairloss believed resumed – Supplemental New Drug Application for Hairloss may be submitted to FDA
Clinical Results:
Much greater and longer inhibition of DHT than Propecia in early testing.
Prior to treatment |
 After 6 months of treatment |
Notes:
The big question will be is it better than Propecia and whether side effects will be greater or more serious. Currently approved form will be a 0.5 mg soft gel.
